There is also evidence of immune system suppression in IDO1-positive advanced BrCa patients as IDO1 expressing breast tumours had higher numbers of infiltrating Tregs in tumour and lymph node metastases [113-115]. This evidence concerns the gene IDO1 and metastatic malignant neoplasm in the lymph nodes.